abbvie reported thirdquarter adjusted earnings that topped analysts’ forecasts and the biopharmaceutical company boosted its profit forecast for the full year the stock was rising 14 in premarket trading friday to 11124 it has risen 24 in 2021 adjusted earnings in the quarter were 333 a share topping forecasts of 321 revenue